|
1
|
Smith PP, Chicca IJ, Heaney JLJ, Muchova M, Khanim FL, Shields AM, Drayson MT, Chapple ILC, Hirschfeld J. Paracetamol suppresses neutrophilic oxygen radicals through competitive inhibition and scavenging. Chem Biol Interact 2024; 404:111283. [PMID: 39428054 DOI: 10.1016/j.cbi.2024.111283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2024] [Revised: 10/07/2024] [Accepted: 10/18/2024] [Indexed: 10/22/2024]
Abstract
Neutrophils, pivotal cells of innate and adaptive immune responses, employ reactive oxygen species (ROS) to combat pathogens and control gene expression. Paracetamol (acetaminophen) is widely used as an analgesic and antipyretic medication, yet its precise mechanisms of action are not yet fully understood. Here, we investigate the impact of both ingested and in-vitro paracetamol on neutrophil ROS activity, using flow cytometry and antioxidant assays. Our studies reveal that paracetamol significantly suppresses ROS activity ex-vivo in the short term. Additionally, both paracetamol and its metabolite N-acetyl-p-benzoquinone imine exhibited direct in vitro antioxidant effects, and paracetamol suppressed neutrophil extracellular trap formation ex vivo. These findings suggest a connection between paracetamol use and altered neutrophil responses, with potential implications for use in some patient groups, such as immunocompromised individuals. Further investigation into paracetamol's effects on neutrophil antimicrobial functions is warranted to elucidate possible risks, particularly when taken frequently or in conjunction with other treatments such as vaccinations.
Collapse
Affiliation(s)
- Peter P Smith
- College of Medicine and Health, School of Health Sciences, Dentistry, Periodontal Research Group, University of Birmingham, Birmingham, UK
| | - Ilaria J Chicca
- College of Medical and Health, School of Infection, Inflammation and Immunology, Clinical Immunology Service, University of Birmingham, Birmingham, UK
| | - Jennifer L J Heaney
- College of Medical and Health, School of Infection, Inflammation and Immunology, Clinical Immunology Service, University of Birmingham, Birmingham, UK
| | - Maria Muchova
- College of Medicine and Health, School of Health Sciences, Dentistry, Periodontal Research Group, University of Birmingham, Birmingham, UK
| | - Farhat L Khanim
- College of Medical and Health, School of Infection, Inflammation and Immunology, Clinical Immunology Service, University of Birmingham, Birmingham, UK
| | - Adrian M Shields
- College of Medical and Health, School of Infection, Inflammation and Immunology, Clinical Immunology Service, University of Birmingham, Birmingham, UK
| | - Mark T Drayson
- College of Medical and Health, School of Infection, Inflammation and Immunology, Clinical Immunology Service, University of Birmingham, Birmingham, UK
| | - Iain L C Chapple
- College of Medicine and Health, School of Health Sciences, Dentistry, Periodontal Research Group, University of Birmingham, Birmingham, UK; Birmingham NIHR Biomedical Research Centre in Inflammation, University of Birmingham, Birmingham, UK.
| | - Josefine Hirschfeld
- College of Medicine and Health, School of Health Sciences, Dentistry, Periodontal Research Group, University of Birmingham, Birmingham, UK; Birmingham NIHR Biomedical Research Centre in Inflammation, University of Birmingham, Birmingham, UK.
| |
Collapse
|
|
4
|
Peela S, Girijashankar V, Ponamgi SPD, Mandali N, Nagaraju GP. Novel tetracycline SBR-22 is a functional moiety deviation and bioactive against multidrug resistant strains. Process Biochem 2019. [DOI: 10.1016/j.procbio.2019.06.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|